IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease

Xiyuan Bai, Alida R. Ovrutsky, Marinka Kartalija, Kathryn Chmura, Amanda Kamali, Jennifer R. Honda, Rebecca E. Oberley-deegan, Charles A. Dinarello, James D. Crapo, Ling Yi Chang, Edward D. Chan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Lung disease due to Mycobacterium avium complex (MAC) organisms is increasing. A greater understanding of the host immune response to MAC organisms will provide a foundation to develop novel therapies for these recalcitrant infections. IL-32 is a newly described pro-inflammatory cytokine that enhances host immunity against various microbial pathogens. Cytokines that induce IL-32 such as interferon-gamma, IL-18, IL-12 and tumor necrosis factor-alpha are of considerable importance to mycobacterial immunity. We performed immunohistochemistry and morphometric analysis to quantify IL-32 expression in the lungs of 11 patients with MAC lung disease and 10 controls with normal lung tissues. After normalizing for basement membrane length, there was a profound increase in IL-32 expression in the airway epithelial cells of the MAC-infected lungs compared with controls. Following normalization for alveolar surface area, there was a trend toward increased IL-32 expression in type II alveolar cells and alveolar macrophages in the lungs of MAC patients. Human airway epithelial cells (BEAS-2B) infected with M. avium produced IL-32 by a nuclear factor-kappa B-dependent mechanism. In both BEAS-2B cells and human monocyte-derived macrophages, exogenous IL-32γ significantly reduced the growth of intracellular M. avium. This finding was corroborated by an increase in the number of intracellular M. avium recovered from THP-1 monocytes silenced for endogenous IL-32 expression. The anti-mycobacterial effect of IL-32 may be due, in part, to increased apoptosis of infected cells. These findings indicate that IL-32 facilitates host defense against MAC organisms but may also contribute to the airway inflammation associated with MAC pulmonary disease.

Original languageEnglish (US)
Pages (from-to)679-691
Number of pages13
JournalInternational Immunology
Volume23
Issue number11
DOIs
StatePublished - Nov 1 2011

Fingerprint

Mycobacterium avium Complex
Lung Diseases
Epithelial Cells
Mycobacterium avium
Lung
Immunity
Cytokines
Alveolar Epithelial Cells
Interleukin-18
NF-kappa B
Alveolar Macrophages
Interleukin-12
Basement Membrane
Interferon-gamma
Monocytes
Tumor Necrosis Factor-alpha
Immunohistochemistry
Macrophages
Apoptosis
Inflammation

Keywords

  • Cytokine
  • Immunohistochemistry
  • Non-tuberculous mycobacteria

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Bai, X., Ovrutsky, A. R., Kartalija, M., Chmura, K., Kamali, A., Honda, J. R., ... Chan, E. D. (2011). IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease. International Immunology, 23(11), 679-691. https://doi.org/10.1093/intimm/dxr075

IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease. / Bai, Xiyuan; Ovrutsky, Alida R.; Kartalija, Marinka; Chmura, Kathryn; Kamali, Amanda; Honda, Jennifer R.; Oberley-deegan, Rebecca E.; Dinarello, Charles A.; Crapo, James D.; Chang, Ling Yi; Chan, Edward D.

In: International Immunology, Vol. 23, No. 11, 01.11.2011, p. 679-691.

Research output: Contribution to journalArticle

Bai, X, Ovrutsky, AR, Kartalija, M, Chmura, K, Kamali, A, Honda, JR, Oberley-deegan, RE, Dinarello, CA, Crapo, JD, Chang, LY & Chan, ED 2011, 'IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease', International Immunology, vol. 23, no. 11, pp. 679-691. https://doi.org/10.1093/intimm/dxr075
Bai, Xiyuan ; Ovrutsky, Alida R. ; Kartalija, Marinka ; Chmura, Kathryn ; Kamali, Amanda ; Honda, Jennifer R. ; Oberley-deegan, Rebecca E. ; Dinarello, Charles A. ; Crapo, James D. ; Chang, Ling Yi ; Chan, Edward D. / IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease. In: International Immunology. 2011 ; Vol. 23, No. 11. pp. 679-691.
@article{ddedf87a812a428f8c557de6dd6d6b3a,
title = "IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease",
abstract = "Lung disease due to Mycobacterium avium complex (MAC) organisms is increasing. A greater understanding of the host immune response to MAC organisms will provide a foundation to develop novel therapies for these recalcitrant infections. IL-32 is a newly described pro-inflammatory cytokine that enhances host immunity against various microbial pathogens. Cytokines that induce IL-32 such as interferon-gamma, IL-18, IL-12 and tumor necrosis factor-alpha are of considerable importance to mycobacterial immunity. We performed immunohistochemistry and morphometric analysis to quantify IL-32 expression in the lungs of 11 patients with MAC lung disease and 10 controls with normal lung tissues. After normalizing for basement membrane length, there was a profound increase in IL-32 expression in the airway epithelial cells of the MAC-infected lungs compared with controls. Following normalization for alveolar surface area, there was a trend toward increased IL-32 expression in type II alveolar cells and alveolar macrophages in the lungs of MAC patients. Human airway epithelial cells (BEAS-2B) infected with M. avium produced IL-32 by a nuclear factor-kappa B-dependent mechanism. In both BEAS-2B cells and human monocyte-derived macrophages, exogenous IL-32γ significantly reduced the growth of intracellular M. avium. This finding was corroborated by an increase in the number of intracellular M. avium recovered from THP-1 monocytes silenced for endogenous IL-32 expression. The anti-mycobacterial effect of IL-32 may be due, in part, to increased apoptosis of infected cells. These findings indicate that IL-32 facilitates host defense against MAC organisms but may also contribute to the airway inflammation associated with MAC pulmonary disease.",
keywords = "Cytokine, Immunohistochemistry, Non-tuberculous mycobacteria",
author = "Xiyuan Bai and Ovrutsky, {Alida R.} and Marinka Kartalija and Kathryn Chmura and Amanda Kamali and Honda, {Jennifer R.} and Oberley-deegan, {Rebecca E.} and Dinarello, {Charles A.} and Crapo, {James D.} and Chang, {Ling Yi} and Chan, {Edward D.}",
year = "2011",
month = "11",
day = "1",
doi = "10.1093/intimm/dxr075",
language = "English (US)",
volume = "23",
pages = "679--691",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease

AU - Bai, Xiyuan

AU - Ovrutsky, Alida R.

AU - Kartalija, Marinka

AU - Chmura, Kathryn

AU - Kamali, Amanda

AU - Honda, Jennifer R.

AU - Oberley-deegan, Rebecca E.

AU - Dinarello, Charles A.

AU - Crapo, James D.

AU - Chang, Ling Yi

AU - Chan, Edward D.

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Lung disease due to Mycobacterium avium complex (MAC) organisms is increasing. A greater understanding of the host immune response to MAC organisms will provide a foundation to develop novel therapies for these recalcitrant infections. IL-32 is a newly described pro-inflammatory cytokine that enhances host immunity against various microbial pathogens. Cytokines that induce IL-32 such as interferon-gamma, IL-18, IL-12 and tumor necrosis factor-alpha are of considerable importance to mycobacterial immunity. We performed immunohistochemistry and morphometric analysis to quantify IL-32 expression in the lungs of 11 patients with MAC lung disease and 10 controls with normal lung tissues. After normalizing for basement membrane length, there was a profound increase in IL-32 expression in the airway epithelial cells of the MAC-infected lungs compared with controls. Following normalization for alveolar surface area, there was a trend toward increased IL-32 expression in type II alveolar cells and alveolar macrophages in the lungs of MAC patients. Human airway epithelial cells (BEAS-2B) infected with M. avium produced IL-32 by a nuclear factor-kappa B-dependent mechanism. In both BEAS-2B cells and human monocyte-derived macrophages, exogenous IL-32γ significantly reduced the growth of intracellular M. avium. This finding was corroborated by an increase in the number of intracellular M. avium recovered from THP-1 monocytes silenced for endogenous IL-32 expression. The anti-mycobacterial effect of IL-32 may be due, in part, to increased apoptosis of infected cells. These findings indicate that IL-32 facilitates host defense against MAC organisms but may also contribute to the airway inflammation associated with MAC pulmonary disease.

AB - Lung disease due to Mycobacterium avium complex (MAC) organisms is increasing. A greater understanding of the host immune response to MAC organisms will provide a foundation to develop novel therapies for these recalcitrant infections. IL-32 is a newly described pro-inflammatory cytokine that enhances host immunity against various microbial pathogens. Cytokines that induce IL-32 such as interferon-gamma, IL-18, IL-12 and tumor necrosis factor-alpha are of considerable importance to mycobacterial immunity. We performed immunohistochemistry and morphometric analysis to quantify IL-32 expression in the lungs of 11 patients with MAC lung disease and 10 controls with normal lung tissues. After normalizing for basement membrane length, there was a profound increase in IL-32 expression in the airway epithelial cells of the MAC-infected lungs compared with controls. Following normalization for alveolar surface area, there was a trend toward increased IL-32 expression in type II alveolar cells and alveolar macrophages in the lungs of MAC patients. Human airway epithelial cells (BEAS-2B) infected with M. avium produced IL-32 by a nuclear factor-kappa B-dependent mechanism. In both BEAS-2B cells and human monocyte-derived macrophages, exogenous IL-32γ significantly reduced the growth of intracellular M. avium. This finding was corroborated by an increase in the number of intracellular M. avium recovered from THP-1 monocytes silenced for endogenous IL-32 expression. The anti-mycobacterial effect of IL-32 may be due, in part, to increased apoptosis of infected cells. These findings indicate that IL-32 facilitates host defense against MAC organisms but may also contribute to the airway inflammation associated with MAC pulmonary disease.

KW - Cytokine

KW - Immunohistochemistry

KW - Non-tuberculous mycobacteria

UR - http://www.scopus.com/inward/record.url?scp=80055120218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055120218&partnerID=8YFLogxK

U2 - 10.1093/intimm/dxr075

DO - 10.1093/intimm/dxr075

M3 - Article

C2 - 22033195

AN - SCOPUS:80055120218

VL - 23

SP - 679

EP - 691

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 11

ER -